Total Payments
$3,437
2023 Payments
$105.29
Companies
30
Transactions
196
Medicare Patients
6,626
Medicare Billing
$244,217
Payment Breakdown by Category
Food & Beverage$3,423 (99.6%)
Education$14.48 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,423 | 195 | 99.6% |
| Education | $14.48 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $689.75 | 42 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $475.92 | 35 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $320.90 | 5 | $0 (2019) |
| Novo Nordisk Inc | $240.96 | 15 | $0 (2023) |
| Amgen Inc. | $202.51 | 13 | $0 (2021) |
| ABBVIE INC. | $177.25 | 12 | $0 (2023) |
| GlaxoSmithKline, LLC. | $147.96 | 2 | $0 (2019) |
| Amarin Pharma Inc. | $138.11 | 8 | $0 (2022) |
| PFIZER INC. | $137.92 | 10 | $0 (2021) |
| Lilly USA, LLC | $125.15 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $105.29 | 6 | ABBVIE INC. ($33.18) |
| 2022 | $357.24 | 20 | Novo Nordisk Inc ($80.94) |
| 2021 | $917.68 | 61 | AstraZeneca Pharmaceuticals LP ($204.81) |
| 2020 | $692.05 | 48 | AstraZeneca Pharmaceuticals LP ($201.61) |
| 2019 | $741.45 | 47 | AstraZeneca Pharmaceuticals LP ($155.69) |
| 2018 | $168.68 | 6 | Merck Sharp & Dohme Corporation ($93.41) |
| 2017 | $455.06 | 8 | Merck Sharp & Dohme Corporation ($204.88) |
All Payment Transactions
196 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/01/2023 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 04/05/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Diabetes | ||||||
| 02/02/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2023 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Endocrinology | ||||||
| 01/06/2023 | Lilly USA, LLC | JARDIANCE (Drug), LYUMJEV | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Diabetes | ||||||
| 11/30/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Diabetes | ||||||
| 11/22/2022 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: Diabetes | ||||||
| 11/15/2022 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: Endocrinology | ||||||
| 11/08/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: TEPEZZA | ||||||
| 11/02/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Diabetes | ||||||
| 10/12/2022 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $20.13 | General |
| Category: Endocrinology | ||||||
| 09/08/2022 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Endocrinology | ||||||
| 09/07/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Diabetes | ||||||
| 08/31/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: PRIMARY CARE | ||||||
| 08/25/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/19/2022 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $17.17 | General |
| Category: Endocrinology | ||||||
| 08/16/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: NEUROSCIENCE | ||||||
| 07/14/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.55 | General |
| 07/12/2022 | Lilly USA, LLC | BAQSIMI (Drug), LYUMJEV | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Diabetes | ||||||
| 06/16/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/26/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Cardiovascular | ||||||
| 05/24/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 179 | 215 | $23,816 | $7,184 |
| 2022 | 14 | 652 | 827 | $94,110 | $42,601 |
| 2021 | 31 | 2,852 | 4,003 | $387,586 | $102,726 |
| 2020 | 38 | 2,943 | 3,982 | $374,987 | $91,707 |
Total Patients
6,626
Total Services
9,027
Medicare Billing
$244,217
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 2 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 24 | 24 | $3,510 | $3,040 | 86.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 269 | 375 | $16,500 | $2,909 | 17.6% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 122 | 172 | $9,976 | $1,663 | 16.7% |
| 82306 | Vitamin d-3 level | Office | 2021 | 47 | 52 | $11,388 | $1,539 | 13.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 295 | 497 | $7,952 | $1,489 | 18.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 92 | 92 | $2,760 | $1,466 | 53.1% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2021 | 59 | 59 | $6,166 | $1,139 | 18.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 19 | 19 | $3,895 | $902.88 | 23.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 59 | 83 | $4,150 | $810.69 | 19.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 108 | 172 | $2,924 | $564.16 | 19.3% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2021 | 21 | 22 | $2,299 | $404.58 | 17.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 14 | 14 | $280.00 | $248.08 | 88.6% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2021 | 24 | 27 | $2,228 | $222.06 | 10.0% |
| 82043 | Urine microalbumin (protein) level | Office | 2021 | 34 | 36 | $2,160 | $208.08 | 9.6% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2021 | 37 | 39 | $1,404 | $202.02 | 14.4% |
| 81002 | Urinalysis, manual test | Office | 2021 | 42 | 43 | $774.00 | $149.64 | 19.3% |
| 83735 | Magnesium level | Office | 2021 | 18 | 19 | $760.00 | $127.30 | 16.8% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2021 | 13 | 14 | $1,092 | $126.28 | 11.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2021 | 28 | 31 | $775.00 | $98.27 | 12.7% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2021 | 15 | 17 | $448.80 | $66.60 | 14.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 16 | 62 | $620.00 | $62.95 | 10.2% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2021 | 27 | 106 | $1,458 | $39.25 | 2.7% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2021 | 12 | 12 | $336.00 | $32.40 | 9.6% |
| 81003 | Automated urinalysis test | Office | 2021 | 14 | 14 | $224.00 | $31.50 | 14.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 312 | 485 | $97,970 | $31,803 | 32.5% |
About Dr. Sheree Nwanegwo, M.D
Dr. Sheree Nwanegwo, M.D is a Family Medicine healthcare provider based in Myrtle Beach, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487610382.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sheree Nwanegwo, M.D has received a total of $3,437 in payments from pharmaceutical and medical device companies, with $105.29 received in 2023. These payments were reported across 196 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,423).
As a Medicare-enrolled provider, Nwanegwo has provided services to 6,626 Medicare beneficiaries, totaling 9,027 services with total Medicare billing of $244,217. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Myrtle Beach, SC
- Active Since 04/21/2006
- Last Updated 11/16/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1487610382
Products in Payments
- XARELTO (Drug) $439.10
- FARXIGA (Drug) $379.91
- JANUMET (Drug) $213.38
- SYMBICORT (Drug) $145.60
- Vascepa (Drug) $138.11
- BEVESPI AEROSPHERE (Drug) $125.00
- JARDIANCE (Drug) $114.97
- JANUVIA (Drug) $107.52
- EVENITY (Biological) $102.79
- Aimovig (Biological) $99.72
- Tymlos (Biological) $92.74
- SOLIQUA 100/33 (Biological) $89.03
- INCRUSE (Drug) $80.59
- RYBELSUS (Drug) $79.68
- TRINTELLIX (Drug) $77.40
- Ozempic (Drug) $77.10
- VRAYLAR (Drug) $71.52
- TRELEGY ELLIPTA (Drug) $67.37
- UBRELVY (Drug) $54.44
- Tresiba (Drug) $51.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Myrtle Beach
Dr. John Karl, Md, MD
Family Medicine — Payments: $15,740
Family Medicine $15,740
Chad Huberty, M.d, M.D
Family Medicine — Payments: $13,773
Family Medicine $13,773
Jeffrey Lindaberry, D.o, D.O
Family Medicine — Payments: $12,797
Family Medicine $12,797
Dr. William Gammon, Md, MD
Family Medicine — Payments: $10,783
Family Medicine $10,783
Dr. Kristen Carr, M.d, M.D
Family Medicine — Payments: $10,590
Family Medicine $10,590
William Prenatt, Md, MD
Family Medicine — Payments: $10,533
Family Medicine $10,533